Latest news with #LifeHealthcare
Yahoo
an hour ago
- Business
- Yahoo
VB Spine Launches in Australia and New Zealand
Stryker's spinal implants business in Australia and New Zealand fully transitions to VB Spine and LifeHealthcare continues as exclusive distributor NEW YORK & SYDNEY, July 31, 2025--(BUSINESS WIRE)--VB Spine LLC ("VB Spine"), a global, family-led spine company dedicated to advancing patient outcomes, announced the completion of the sale of Stryker's spinal implants business in Australia and New Zealand. This milestone builds upon the formation of VB Spine on April 1, 2025, following the acquisition of Stryker's U.S. spinal implants business by Viscogliosi Brothers, LLC. It also marks VB Spine's first market entry outside the United States and establishes a direct presence in two fast-growing markets. VB Spine continues to have exclusive access to Stryker's Mako Spine and the Copilot automatic depth stop feature. This strategic partnership creates a strong foundation for VB Spine's continued growth, providing surgeons greater precision and improving patient outcomes. "From the start, our vision has been simple: put patients first and innovate boldly," said Marc Viscogliosi, co-CEO of VB Spine, speaking for his brothers and fellow co-CEOs Anthony and John Viscogliosi. "Today we take that vision global. By combining the passion of our family-run culture with LifeHealthcare's best-in-class surgeon support, we're opening a new chapter in spine care defined by access, outcomes, and possibility." LifeHealthcare, already the long-standing distributor for these products, will continue as the exclusive partner, providing uninterrupted product availability and clinical support for surgeons and their patients throughout Australia and New Zealand. Paul Petherbridge, CEO of LifeHealthcare, said, "We are pleased to announce our long-term collaboration with VB Spine. LifeHealthcare has represented this portfolio since 2010, providing clinicians and patients in Australia and New Zealand with reliable access to spinal instrumentation and implants through our experienced team. Our partnership with VB Spine aligns with our mission for Spine in ANZ: 'What matters to you drives us.' We look forward to working with the Viscogliosi brothers and the VB Spine team to offer innovative solutions and valuable education to our clinicians." Transition highlights All current spinal implant SKUs remain available through LifeHealthcare with no service interruption. Surgeons and hospitals will continue to work with their local LifeHealthcare representatives. VB Spine plans to attend Deformity Down Under (DDU) in Brisbane, which began as a surgeon-led initiative to foster collaboration, share knowledge, and improve outcomes in spine surgery. Forward-looking statements Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law. Transaction financing Viscogliosi Brothers, LLC and Viscogliosi Brothers Watermark Holdings LLC are equity investors in VB Spine. About VB Spine VB Spine LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. With a comprehensive product portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes. Focused on people, partnerships and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers. For more information on VB Spine, please visit About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at About LifeHealthcare Distribution Pty Ltd (Australia) and LifeHealthcare Ltd (New Zealand) LifeHealthcare, an EBOS MedTech company, is committed to providing patients in Australia and New Zealand with access to world-class medical devices and technology. Our goal is to ensure the long-term economic sustainability of the healthcare system. We offer a diverse range of products across various channels for surgical intervention, including but not limited to therapeutic areas such as Spine and Enabling Technology, Orthopaedics (Reconstruction, Extremities, and Regenerative Medicine), Plastics and Reconstructive Surgery, Neurovascular Intervention, Abdo-Pelvic Surgery, and Neurosurgery, among others. For more information about LifeHealthcare, please visit or About Viscogliosi Brothers Viscogliosi Brothers, LLC is a family-owned New York City-based family office dedicated to driving growth and innovation in the neuro-musculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system. Since its inception 26 years ago, Viscogliosi Brothers has founded, financed, operated and grown 43 businesses with operations and distribution across more than 80 countries. These businesses have positively impacted millions of patients with cutting-edge innovations in healthcare. The firm has led the transformation of the spine industry through its multiple businesses specifically including: Spine Solutions, Spine Next, Paradigm Spine, Simplify Medical, Centinel Spine, Companion Spine, Spine BioPharma and Woven Orthopedic Technologies, among others. For more information, visit About Viscogliosi Brothers Watermark Viscogliosi Brothers Watermark LLC is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating alternative wealth for its shareholders while enhancing humanity's well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing capabilities. For more information, visit View source version on Contacts For media inquiries only: vbspinecommunications@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business
- Business Wire
VB Spine Launches in Australia and New Zealand
NEW YORK & SYDNEY--(BUSINESS WIRE)-- VB Spine LLC ('VB Spine'), a global, family-led spine company dedicated to advancing patient outcomes, announced the completion of the sale of Stryker's spinal implants business in Australia and New Zealand. This milestone builds upon the formation of VB Spine on April 1, 2025, following the acquisition of Stryker's U.S. spinal implants business by Viscogliosi Brothers, LLC. It also marks VB Spine's first market entry outside the United States and establishes a direct presence in two fast-growing markets. VB Spine continues to have exclusive access to Stryker's Mako Spine and the Copilot automatic depth stop feature. This strategic partnership creates a strong foundation for VB Spine's continued growth, providing surgeons greater precision and improving patient outcomes. 'From the start, our vision has been simple: put patients first and innovate boldly,' said Marc Viscogliosi, co-CEO of VB Spine, speaking for his brothers and fellow co-CEOs Anthony and John Viscogliosi. 'Today we take that vision global. By combining the passion of our family-run culture with LifeHealthcare's best-in-class surgeon support, we're opening a new chapter in spine care defined by access, outcomes, and possibility.' LifeHealthcare, already the long-standing distributor for these products, will continue as the exclusive partner, providing uninterrupted product availability and clinical support for surgeons and their patients throughout Australia and New Zealand. Paul Petherbridge, CEO of LifeHealthcare, said, 'We are pleased to announce our long-term collaboration with VB Spine. LifeHealthcare has represented this portfolio since 2010, providing clinicians and patients in Australia and New Zealand with reliable access to spinal instrumentation and implants through our experienced team. Our partnership with VB Spine aligns with our mission for Spine in ANZ: 'What matters to you drives us.' We look forward to working with the Viscogliosi brothers and the VB Spine team to offer innovative solutions and valuable education to our clinicians.' Transition highlights All current spinal implant SKUs remain available through LifeHealthcare with no service interruption. Surgeons and hospitals will continue to work with their local LifeHealthcare representatives. VB Spine plans to attend Deformity Down Under (DDU) in Brisbane, which began as a surgeon-led initiative to foster collaboration, share knowledge, and improve outcomes in spine surgery. Forward-looking statements Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law. Transaction financing Viscogliosi Brothers, LLC and Viscogliosi Brothers Watermark Holdings LLC are equity investors in VB Spine. About VB Spine VB Spine LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. With a comprehensive product portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes. Focused on people, partnerships and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers. For more information on VB Spine, please visit About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at About LifeHealthcare Distribution Pty Ltd (Australia) and LifeHealthcare Ltd (New Zealand) LifeHealthcare, an EBOS MedTech company, is committed to providing patients in Australia and New Zealand with access to world-class medical devices and technology. Our goal is to ensure the long-term economic sustainability of the healthcare system. We offer a diverse range of products across various channels for surgical intervention, including but not limited to therapeutic areas such as Spine and Enabling Technology, Orthopaedics (Reconstruction, Extremities, and Regenerative Medicine), Plastics and Reconstructive Surgery, Neurovascular Intervention, Abdo-Pelvic Surgery, and Neurosurgery, among others. For more information about LifeHealthcare, please visit or About Viscogliosi Brothers Viscogliosi Brothers, LLC is a family-owned New York City-based family office dedicated to driving growth and innovation in the neuro-musculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system. Since its inception 26 years ago, Viscogliosi Brothers has founded, financed, operated and grown 43 businesses with operations and distribution across more than 80 countries. These businesses have positively impacted millions of patients with cutting-edge innovations in healthcare. The firm has led the transformation of the spine industry through its multiple businesses specifically including: Spine Solutions, Spine Next, Paradigm Spine, Simplify Medical, Centinel Spine, Companion Spine, Spine BioPharma and Woven Orthopedic Technologies, among others. For more information, visit About Viscogliosi Brothers Watermark Viscogliosi Brothers Watermark LLC is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating alternative wealth for its shareholders while enhancing humanity's well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing capabilities. For more information, visit
Zawya
30-06-2025
- Health
- Zawya
South Africa: Medshield is committed to building a sustainable healthcare future
Are you curious about what makes businesses stand out in our current environment? It's certainly not about the bottom line and the financials anymore. It's about how they impact the world – the environment, the societies in which they operate, and their governance structures. Environmental, Social, and Governance (ESG) principles have become indispensable in a world grappling with climate change, social inequalities, and corporate accountability. While sectors like mining, energy, and manufacturing have typically been under the ESG spotlight, healthcare is now stepping into focus. Integrating ESG principles is crucial for medical schemes to ensure the future sustainability of healthcare. Factors such as escalating costs, the rise of lifestyle-related diseases, and the environmental impact of medical waste make ESG adoption necessary. Medshield Medical Scheme aligns sustainability with healthcare excellence by developing an ESG roadmap featuring clear corporate sustainability goals. This effort sets the benchmark for responsible healthcare funding in South Africa, paving the way for a more resilient healthcare system. Learning from South African ESG leaders Medshield acknowledges the importance of gaining insights from industry leaders who have effectively integrated ESG principles into their business models. Locally, Life Healthcare is actively driving sustainable healthcare by incorporating energy efficiency and water-saving measures across its hospital network. Aspen Pharmacare, one of South Africa's largest pharmaceutical companies, has embedded ESG principles into its global operations – most notably with sustainable manufacturing practices and community health support initiatives. Sanlam has demonstrated leadership in sustainable investment practices, governance transparency, and transformation targets in the insurance sector, aligning financial strength with social progress. Novartis South Africa also contributes to local ESG progress through public-private partnerships to expand access to healthcare and drive inclusive health equity. By benchmarking against these homegrown leaders and learning from their practical examples, Medshield aims to refine and strengthen its ESG roadmap. Although still in its preliminary stages, Medshield is laying the foundation for meaningful impact. 1. Environmental impact: Pollution and waste management Environmental sustainability is a fundamental ESG pillar, and healthcare providers must tackle pollution and waste management. The healthcare sector produces substantial medical, pharmaceutical, and electronic waste, which can result in severe environmental consequences if not meticulously managed. Life Healthcare has taken a proactive role in managing medical waste and improving energy usage within hospital environments. Aspen Pharmacare has also been recognised for its commitment to reducing environmental impact through improved production technologies and waste reduction systems. Inspired by these local initiatives, Medshield is exploring energy-efficient infrastructure and renewable energy solutions to reduce its environmental footprint and contribute to sustainable healthcare. 2. Social impact: Climate change and human health Climate change poses an escalating threat to public health. Rising temperatures and pollution levels contribute to lifestyle ailments such as hypertension, diabetes, and respiratory conditions. Medshield recognises its responsibility to mitigate these health risks through preventive healthcare programmes, chronic disease management, and promoting wellness benefits to its members. In parallel, Novartis South Africa continues to lead in raising awareness and improving access to treatment for chronic diseases, with a focus on underserved communities. Medshield similarly integrates ESG principles across its internal operations to ensure alignment with corporate sustainability goals and regulatory compliance while supporting climate resilience through health. 3. Corporate responsibility: Social initiatives and member engagement ESG leaders in South Africa prioritise healthcare access and equity. Medshield is committed to extending its corporate responsibility beyond its members. The Scheme supports community health initiatives, wellness programmes, and financial literacy education. Additionally, Medshield embeds ESG principles into its corporate culture – ensuring staff engagement and promoting awareness about lifestyle changes that contribute to improved health outcomes. Aspen Pharmacare, for instance, has significantly contributed to healthcare equity through community-based partnerships and access to essential medicines. Sanlam has also implemented financial literacy initiatives nationwide to drive socioeconomic upliftment. Medshield is actively learning from and contributing to this ecosystem of shared value creation. 4. Governance: The pillar of corporate sustainability Strong governance ensures transparency, accountability, and long-term sustainability. Medshield prides itself on having a robust governance structure and is adopting best practices to strengthen its corporate governance. The Scheme is exploring partnerships with ESG-focused healthcare networks for ongoing improvement and intends to integrate ESG reporting into its annual trustee and Annual General Meeting (AGM) reports to strengthen transparency and accountability. Sanlam's comprehensive sustainability disclosures and Life Healthcare's transparent ESG frameworks offer useful templates for Medshield's ongoing governance enhancement. By drawing from these examples, Medshield aims to ensure that ESG isn't a side initiative but a core part of the Scheme's operation. Medshield is a responsible corporate citizen Medshield's ESG journey signifies its dedication to being a responsible corporate citizen. By embedding ESG principles into its business model, Medshield enhances its reputation and safeguards its operations against emerging global challenges. As one of the pioneers among South African medical schemes in undertaking a structured ESG journey, Medshield is setting a noteworthy precedent. Its approach emphasises long-term resilience, sustainability, and member-centric healthcare solutions. As Medshield refines its ESG initiatives, the greater healthcare sector benefits from a model prioritising people, the planet, and strong governance. ESG is not merely a trend – it is the future of responsible healthcare, and Medshield is at the forefront of this transformation in South Africa. We invite all members, brokers, and stakeholders to join us in shaping a more sustainable and inclusive healthcare future.
The Citizen
29-06-2025
- Health
- The Citizen
Investigations after patients accuse Durban cardiologist of malpractice
The Health Professions Council of South Africa (HPCSA) is investigating claims of medical malpractice by a cardiologist at Life Westville Hospital in Durban, accused of performing unnecessary surgical procedures. According to the Rising Sun, more than five patients have come forward with allegations against Ntando Duze, a doctor with admitting rights at the hospital. The patients allege they were subjected to invasive procedures, including the insertion of stents, which they believe were not medically necessary. The allegations, which have raised alarm among both patients and medical professionals, were brought to the attention of Life Healthcare and the HPCSA. Complainants say the procedures caused more harm than healing and questioned whether proper informed consent was obtained. In response to media queries, Life Healthcare confirmed that it was informed of the allegations by the HPCSA and has since launched an internal review. 'Upon receiving this information, we promptly provided the relevant details and initiated our own internal review process in accordance with our robust clinical management protocols. Our investigation is still ongoing, and we are therefore not in a position to disclose further details at this stage,' said Dr Karisha Quarie, the chief medical officer at the hospital. While the exact number and nature of complaints remain undisclosed, the hospital group said it takes such allegations seriously and is committed to acting on the findings once the review is concluded. Dr Quarie emphasised that Dr Duze, like many specialists operating at Life facilities, is not an employee but an independent healthcare practitioner with admitting rights. 'This distinction underscores that, while they provide essential medical services within our facilities, they operate independently,' she explained. Life Healthcare reiterated its commitment to patient safety and quality care, stating: 'Our primary concern is always the well-being and safety of our patients.' Breaking news at your fingertips… Follow Caxton Network News on Facebook and join our WhatsApp channel. Nuus wat saakmaak. Volg Caxton Netwerk-nuus op Facebook en sluit aan by ons WhatsApp-kanaal. Read original story on At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
eNCA
23-05-2025
- Business
- eNCA
Plans to build new hospital in Paarl
JOHANNESBURG - Life Healthcare has plans to build a 140-bed hospital in Paarl, Western Cape. It's part of the hospital group's strategy to grow its footprint across the country. The group released its interim results on Thursday. Revenue from continuing operations increased by 8.1 percent to R12.1-billion for the six months ended 31 March. The group benefited from the growth of paid patient days and an overall increase in demand for its services, including mental health.
